WealthTrust Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Sell
2,151
-62
-3% -$63.3K 1.4% 15
2026
Q1
$2.04M Buy
2,213
+638
+41% +$647K 1.22% 19
2025
Q4
$1.69M Buy
1,575
+512
+48% +$490K 1.18% 20
2025
Q3
$811K Sell
1,063
-175
-14% -$130K 0.56% 43
2025
Q2
$965K Sell
1,238
-68
-5% -$52.8K 0.72% 31
2025
Q1
$1.08M Sell
1,306
-596
-31% -$496K 0.8% 27
2024
Q4
$1.47M Sell
1,902
-33
-2% -$27.3K 1.05% 24
2024
Q3
$1.71M Sell
1,935
-1,091
-36% -$981K 1.28% 20
2024
Q2
$2.74M Sell
3,026
-18
-0.6% -$14.4K 2% 14
2024
Q1
$2.37M Buy
3,044
+4
+0.1% +$2.85K 1.8% 14
2023
Q4
$1.77M Sell
3,040
-208
-6% -$121K 1.49% 18
2023
Q3
$1.74M Buy
+3,248
New +$1.67M 1.62% 17

Other funds holding LLY

WealthTrust Asset Management's LLY Position: Q2 2026 in Review

WealthTrust Asset Management reduced its Eli Lilly (LLY) stake by 2.8% in Q2 2026, selling an estimated $63.3K and leaving 2,151 shares worth $2.58M. The position accounts for 1.4% of the portfolio, ranked #15.

WealthTrust Asset Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.74M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • WealthTrust Asset Management held 2,151 shares of Eli Lilly worth $2.58M as of Q2 2026.
  • WealthTrust Asset Management sold 62 Eli Lilly shares in Q2 2026, an estimated $63.3K.
  • Eli Lilly made up 1.4% of WealthTrust Asset Management's portfolio in Q2 2026, its #15 holding.
  • WealthTrust Asset Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • WealthTrust Asset Management's Eli Lilly position peaked at $2.74M in Q2 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on WealthTrust Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.